QUECTEL-WIRELESS
10.1.2024 18:01:36 CET | Business Wire | Press release
CES – Quectel Wireless Solutions, a global IoT solutions provider, is pleased to announce the successful certification of Quectel's NTN-enabled module, the CC660D-LS, for use on the network by Skylo, the leading non-terrestrial network (NTN) service provider. The module is the first to be certified by Skylo for use on its network and enables seamless and reliable IoT-NTN connectivity for any standard device that incorporates the module and has a view of the sky.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240110653580/en/
Quectel announces industry-first certification of satellite communication module on Skylo network (Photo: Business Wire)
Quectel has developed the CC660D-LS module specifically to provide dependable and efficient, two-way, satellite communication capabilities. With the module's certification on the Skylo network, businesses and organizations can harness the power of Skylo's ubiquitous satellite connectivity to enable IoT applications in remote and challenging environments, ensuring that data is transmitted securely and reliably.
The CC660D-LS module provides a range of flexible connectivity options, encompassing L-band, S-band, and Band 23 connections. Notably, this module is equipped to support 3GPP Release 17 IoT non-terrestrial network (IoT-NTN) connections, reflecting its advanced capabilities. Prioritizing reliable connectivity, the CC660D-LS module excels in facilitating two-way communication. Furthermore, the module extends its support to both IP and Non-IP service networks. This dual capability ensures not only enhanced connectivity but also heightened service availability. The CC660D-LS module stands as a comprehensive solution for robust and versatile connectivity needs.
"We are delighted that Skylo has certified our NTN Satellite Communication Module for its network," said Norbert Muhrer, President and CSO, Quectel Wireless Solutions. "This certification reflects our commitment to delivering high-quality satellite communication solutions to our customers worldwide. By collaborating with Skylo, we enable businesses to unlock new opportunities and achieve their IoT goals, regardless of where they are located."
The Skylo certification process involved rigorous testing and evaluation to ensure that the CC660D-LS module meets stringent quality and performance standards, including 3GPP Release-17 standards and Skylo's Standards Plus qualifications. Skylo's network is designed to provide global coverage, ensuring that IoT devices equipped with Quectel's module can stay connected in areas with limited terrestrial infrastructure.
"We are excited to welcome Quectel's CC660D-LS module to our ecosystem of certified devices," said Dr Andrew Nuttall, CTO and Co-Founder of Skylo. "This certification is a testament to our commitment to providing the most reliable and expansive satellite based IoT connectivity. By partnering with industry leaders like Quectel, we empower device manufacturers of all types to expand their IoT applications, add additional review streams, and deliver a superior customer experience that requires no change in user behavior."
Quectel's CC660D-LS module is suitable for a wide range of applications, including asset tracking, fleet management, agriculture, maritime, and more. The module's compact design and low-power consumption make it an ideal choice for battery-powered IoT devices that require long-term, uninterrupted connectivity.
Quectel’s IoT modules are developed with security at the core. From product architecture to firmware/software development, Quectel incorporates leading industry practices and standards, mitigating potential vulnerabilities with third party independent test houses and have incorporated security practices like generating SBOMs and VEX files as well as performing firmware binary analysis into the entire software development lifecycle.
IoT developers now can streamline their development process by combining Quectel modules with Quectel's antennas and pre-certification services, effectively reducing both costs and time-to-market for their IoT devices. For the CC660D-LS satellite module, Quectel offers the YECN028AA and YFCA011AA antennas, providing developers with versatile options to enhance connectivity and expedite the deployment of their innovative solutions.
About Quectel
Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global IoT solutions provider backed by outstanding support and services. Our growing global team of 5,900 professionals sets the pace for innovation in cellular, GNSS, Wi-Fi and Bluetooth modules as well as antennas and services.
With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.
For more information, please visit: www.quectel.com, LinkedIn, Facebook, and X.
About Skylo
Skylo Technologies is an NTN service provider based in Mountain View, CA, offering a service that allows cellular modems and devices to connect directly over existing satellites. Devices connected over satellite are managed and served by Skylo’s commercial NTN vRAN, featuring a 3GPP standards-based cloud-native base station and core. Skylo works with existing satellite operators, terrestrial mobile network operators, and device makers to provide subscribers an anywhere, anytime connectivity solution that seamlessly roams between terrestrial and satellite networks. Skylo’s focus is on enabling connected services for people outdoors and connected workflows for machines at work across critical industries such as agriculture, maritime, logistics, mining, and others, in addition to mass-market consumer devices. For more information, visit www.skylo.tech, contact info@skylo.tech, or follow us on LinkedIn and Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240110653580/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom